Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04488354 · ClinicalTrials.gov registry record · Phase 1
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
A Phase 1 study, sponsored by Calibr, a division of Scripps Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT04488354: Completed Phase 1 study, sponsored by Calibr, a division of Scripps Research.
NCT04488354 is a Phase 1 study that has completed, run by Calibr, a division of Scripps Research. The registered enrollment target is 16 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04488354, a Phase 1 study, has completed, sponsored by Calibr, a division of Scripps Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is designed as a long-term follow-up study of participants who have receive genetically modified autologous CLBR001 CAR-T cells
Primary Outcome
To measure the incidence and duration of new adverse events, late onset adverse events, and events of special interest
Interventions
- COMBINATION_PRODUCT CLBR001 and SWI019
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2025-10-06 |
| Phase | Phase 1 |
What the finished NCT04488354 record still lists
NCT04488354 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 1 intervention - of which CLBR001 and SWI019 is the first listed.
NCT04488354 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04488354 about?
NCT04488354 is a clinical study titled "Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T". This study is designed as a long-term follow-up study of participants who have receive genetically modified autologous CLBR001 CAR-T cells
What is the current status of trial NCT04488354?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2021-01-21. Estimated completion is 2025-10-06.
What interventions are being tested in trial NCT04488354?
The interventions under investigation include: CLBR001 and SWI019 (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04488354?
This trial is sponsored by Calibr, a division of Scripps Research, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04488354's enrollment target sits among peer trials
16 1786th of 2000 higher than 203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI